Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2025
2025-07-02 08:05
Prolight’s rights issue fully subscribed
Regulatory
MAR
2025-06-30 17:50
Prolight announces preliminary outcome of the rights issue
Regulatory
MAR
2025-06-30 14:40
Annual general meeting of Prolight Diagnostics AB (publ) on 30 June 2025
Regulatory
2025-06-27 08:00
Prolight Diagnostics showcases Psyros™ at ADLM 2025 in Chicago
2025-06-25 08:00
The last day of trading in subscription rights in Prolight’s rights issue
Regulatory
2025-06-23 19:00
Prolight announces additional subscription commitments from the board, management and existing shareholders
2025-06-19 09:30
Prolight announces appointment of Professor Matt Reed to Clinical Advisory Board
2025-06-18 08:15
Emergers publishes updated analysis for Prolight Diagnostics
2025-06-17 18:40
Prolight invites to digital investor meeting due to recent achieved milestones
2025-06-17 09:31
Prolight receives notice of allowance in Japan for core patent related to Psyros™ technology
Next
